Genmab

From WikiMD.com Medical Encyclopedia


Overview[edit | edit source]

Genmab logo

Genmab is a biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer and other serious diseases. Founded in 1999, Genmab is headquartered in Copenhagen, Denmark, with additional offices in Utrecht, Netherlands, and Princeton, New Jersey, United States.

History[edit | edit source]

Genmab was established in 1999 by a team of scientists and entrepreneurs with the goal of developing innovative antibody-based therapies. The company quickly gained recognition for its proprietary technology platforms and its ability to generate high-quality therapeutic antibodies.

Technology Platforms[edit | edit source]

Genmab utilizes several proprietary technology platforms to develop its antibody therapeutics. These include:

  • DuoBody® Platform: A technology for generating bispecific antibodies that can bind to two different targets simultaneously.
  • HexaBody® Platform: A technology designed to enhance the potency of antibodies by inducing hexamer formation.
  • HexElect® Platform: A platform that combines the HexaBody and DuoBody technologies to create potent bispecific antibodies.

Key Products[edit | edit source]

Genmab has developed several key products that have been approved for clinical use or are in various stages of clinical development. Some of these include:

  • Darzalex® (daratumumab): An antibody used in the treatment of multiple myeloma.
  • Kesimpta® (ofatumumab): An antibody used for the treatment of relapsing forms of multiple sclerosis.

Research and Development[edit | edit source]

Genmab is committed to advancing its pipeline of antibody therapeutics through rigorous research and development. The company collaborates with various academic institutions and pharmaceutical companies to enhance its R&D capabilities.

Collaborations and Partnerships[edit | edit source]

Genmab has established strategic partnerships with several leading pharmaceutical companies, including Johnson & Johnson and Novartis, to co-develop and commercialize its antibody products.

Corporate Social Responsibility[edit | edit source]

Genmab is dedicated to conducting its business in a socially responsible manner. The company focuses on sustainability, ethical business practices, and contributing to the communities in which it operates.

See Also[edit | edit source]

Related Pages[edit | edit source]

WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD